Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | AMGN | GILD | BIIB | CELG |
| Company | Ultragenyx Pharmaceu | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 58.54 | 337.03 | 84.39 | 200.57 | 108.01 |
| High | 59.90 | 338.70 | 84.65 | 204.18 | 108.59 |
| Low | 58.21 | 334.61 | 83.57 | 200.11 | 107.27 |
| Last | 59.21 | 336.90 | 84.40 | 202.81 | 108.24 |
| Change | +1.51 | +3.98 | +0.51 | +5.22 | +0.11 |
| % Change | +2.62% | +1.20% | +0.61% | +2.64% | +0.10% |
| Volume | 178,164 | 520,086 | 2,877,681 | 404,860 | 191,230,496 |
| 20-Day Average Volume | 602,276 | 1,704,359 | 6,388,822 | 791,635 | 16,188,930 |
| Previous Close | 57.70 | 332.92 | 83.89 | 197.59 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 57.12 | 329.61 | 80.10 | 201.61 | 108.17 |
| 20-Day Raw Stochastic | 84.86% | 87.65% | 95.65% | 64.27% | 63.25% |
| 20-Day Relative Strength | 67.22% | 58.10% | 72.95% | 45.40% | 64.69% |
| Weighted Alpha | +71.29 | +27.40 | +19.35 | -21.55 | +46.30 |
| Today's Opinion | 88% Buy | 96% Buy | 88% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 88% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 56% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.91% since 09/12/24 | +1.96% since 09/12/24 | +1.58% since 09/12/24 | +1.86% since 09/12/24 | -1.97% since 11/13/19 |
| Low | 57.44 on 09/18/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 192.25 on 09/13/24 | 107.27 on 11/20/19 |
| High | 60.37 on 09/16/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 204.18 on 09/19/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +10.65% since 08/19/24 | +2.61% since 08/19/24 | +13.47% since 08/19/24 | -2.18% since 08/19/24 | +5.14% since 10/18/19 |
| Low | 52.63 on 08/20/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
| High | 60.37 on 09/16/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +59.03% since 06/18/24 | +9.98% since 06/18/24 | +33.77% since 06/18/24 | -9.87% since 06/18/24 | +13.63% since 08/20/19 |
| Low | 37.27 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
| High | 60.37 on 09/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +26.62% since 03/19/24 | +23.85% since 03/19/24 | +15.07% since 03/19/24 | -7.80% since 03/19/24 | +14.14% since 05/20/19 |
| Low | 37.02 on 06/18/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 60.37 on 09/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,796,775 | 178,589,936 | 104,514,608 | 28,768,510 | 77,035,920 |
| Shares Outstanding, K | 83,133 | 536,435 | 1,245,853 | 145,597 | 711,714 |
| Annual Sales | 434,250,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -606,640,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 147,030,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
| Last Quarter Net Income | -131,600,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
| 60-Month Beta | 0.56 | 0.61 | 0.18 | -0.06 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 08/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/05/24 | 08/01/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 12.19 | 10.99 |